Neuropathology and Biochemistry Core
神经病理学和生物化学核心
基本信息
- 批准号:10237299
- 负责人:
- 金额:$ 39.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-20 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AliquotAlzheimer&aposs disease related dementiaAmericanAmyloidAmyloid beta-42Amyloid beta-ProteinAreaAutopsyBiochemistryBrainBrain regionCerebellumClinicClinicalClinical ResearchCollaborationsConsensusCorrelative StudyCryoelectron MicroscopyDNADataData CollectionDementiaDementia with Lewy BodiesDepositionDiagnosticDiagnostics ResearchDiseaseEducation and OutreachEducational ActivitiesEvaluationExperimental DesignsFreezingFrequenciesGeneticGoalsHistologicHistologyHumanImage AnalysisImmunohistochemistryIndividualInstitutionLesionLewy BodiesLewy Body DementiaLewy neuritesLiquid substanceMeasuresMethodsMicroscopyMolecularNeurofibrillary TanglesNitrogenOnline SystemsParaffinParkinson DiseaseParkinson&aposs DementiaParkinsonian DisordersPathologicPathologyPatientsPersonsPowder dose formPreparationProcessProteinsProteomicsRecommendationReportingResearchResearch PersonnelResearch Project GrantsResolutionResourcesSamplingScientistSenile PlaquesSolubilityStandardizationStructureSubstantia nigra structureSuperior temporal gyrusTauopathiesThioflavin STissue SampleTissuesTranslational ResearchTyrosine 3-MonooxygenaseUnited States National Institutes of Healthalpha synucleinbasebrain tissuecase controlclinical subtypesdata sharingdigitaldigital pathologyendophenotypegenetic analysisgenetic informationinstrumentlipidomicsmechanical forcemicroscopic imagingneuron lossneuropathologypatient outreachprotein TDP-43protein profilingputamenrelational databaseresearch studystatisticstau Proteinstau aggregationtau-1tissue processingtraittranscriptomics
项目摘要
PROJECT SUMMARY – NEUROPATHOLOGY AND BIOCHEMISTRY CORE
Neuropathologic evaluation remains an important part of clinical and translational research on dementia with
Lewy bodies (DLB) and Parkinsonian disease dementia (PDD), disorders that have been grouped in the
research recommendations of NIH-sponsored Alzheimer Disease and Related Dementias (ADRD)
recommendations as the Lewy body dementias (LBD). The purpose of the Core B: Neuropathology is to
perform quantitative postmortem neuropathologic evaluations and data collection for all LBD brains that will be
distributed to the CWOW scientists. The Core B will provide pulverized frozen human brain samples, brain
homogenates, purified protein preparations (Aβ and α-Syn) or paraffin sections of LBD cases and matched
controls to all CWOW investigators, as well as to qualified investigators at other research institutions as
approved by the Executive Committee of Core A and the Mayo Clinic Biospecimen Committee. The
quantitative traits generated include counts of cortical Lewy bodies, semiquantitative estimates of substantia
nigra neuronal loss, dopaminergic deficiency in putamen with tyrosine hydroxylase immunohistochemistry and
counts of senile plaques and neurofibrillary tangles in cortical and subcortical areas with thioflavin S
fluorescent microscopy. Core B will perform digital microscopy and image analysis on sections processed for
immunohistochemistry for α-Syn, phospho-tau and Aβ40, Aβ42, as additional other quantitative
endophenotypes, such as phospho-TDP-43.
项目总结-神经病理学和生化学核心
神经病理学评估仍然是痴呆症临床和转化研究的重要组成部分,
路易体(DLB)和帕金森病痴呆(PDD),这些疾病已被分组在
美国国立卫生研究院资助的阿尔茨海默病和相关痴呆症(ADRD)的研究建议
路易体痴呆(Lewy Body Dementias,LBD)核心B:神经病理学的目的是
对所有LBD的大脑进行定量的死后神经病理学评估和数据收集,
分发给CWOW科学家。核心B将提供粉碎的冷冻人脑样本,
组织匀浆、纯化蛋白制剂(Aβ和α-Syn)或LBD病例的石蜡切片,
所有CWOW研究者以及其他研究机构的合格研究者,
由核心A执行委员会和马约诊所生物标本委员会批准。的
产生的数量性状包括皮质路易体的计数,
黑质神经元丢失,壳核多巴胺能缺乏,酪氨酸羟化酶免疫组织化学和
用硫磺素S计数皮质和皮质下区域的老年斑和神经纤维缠结
荧光显微镜核心B将对处理后的切片进行数字显微镜检查和图像分析,
α-Syn、磷酸化tau和Aβ40、Aβ42的免疫组织化学,作为额外的其他定量
内表型,如磷酸-TDP-43。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS WILLIAM DICKSON其他文献
DENNIS WILLIAM DICKSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS WILLIAM DICKSON', 18)}}的其他基金
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia
路易体痴呆中β淀粉样蛋白和α-突触核蛋白的协同相互作用
- 批准号:
10478180 - 财政年份:2019
- 资助金额:
$ 39.26万 - 项目类别:
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia
路易体痴呆中β淀粉样蛋白和α-突触核蛋白的协同相互作用
- 批准号:
10022170 - 财政年份:2019
- 资助金额:
$ 39.26万 - 项目类别:
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia
路易体痴呆中β淀粉样蛋白和α-突触核蛋白的协同相互作用
- 批准号:
10237297 - 财政年份:2019
- 资助金额:
$ 39.26万 - 项目类别:
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia
路易体痴呆中β淀粉样蛋白和α-突触核蛋白的协同相互作用
- 批准号:
10686893 - 财政年份:2019
- 资助金额:
$ 39.26万 - 项目类别: